Copyright
©The Author(s) 2023.
World J Orthop. Jun 18, 2023; 14(6): 443-457
Published online Jun 18, 2023. doi: 10.5312/wjo.v14.i6.443
Published online Jun 18, 2023. doi: 10.5312/wjo.v14.i6.443
Subscale | Knee osteoarthritis (n = 824) – KOOS scale | P valuea | ||||
Visit 1, baseline, n = 824 | Visit 2, week 16-24, n = 798 | Visit 3 week 36-44, n = 794 | Visit 4, week 56-64, n = 794 | Changes from baseline on visit 4 | ||
Pain | 61.48 (60.36-62.61) | 79.59 (78.48-80.70) | 82.50 (81.45-83.56) | 84.24 (83.15-85.34) | 22.87 (21.56-24.18) | < 0.001 |
Symptoms | 62.25 (61.02-63.48) | 77.65 (76.46-78.84) | 81.09 (79.97-82.21) | 82.80 (81.66-83.93) | 20.78 (19.43-22.13) | < 0.001 |
Functional activity of the joint | 61.46 (60.73-62.18) | 72.48 (71.63-73.34) | 75.78 (74.86-76.69) | 78.03 (77.06-78.99) | 16.60 (15.59-17.61) | < 0.001 |
Quality of life | 44.99 (43.83-46.16) | 61.40 (60.10-62.69) | 65.91 (64.54-67.27) | 69.92 (68.45-71.39) | 24.87 (23.41-26.34) | < 0.001 |
- Citation: Lila AM, Alekseeva LI, Baranov AA, Taskina EA, Kashevarova NG, Lapkina NA, Trofimov EA. Chondroitin sulfate and glucosamine combination in patients with knee and hip osteoarthritis: A long-term observational study in Russia. World J Orthop 2023; 14(6): 443-457
- URL: https://www.wjgnet.com/2218-5836/full/v14/i6/443.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i6.443